Literature DB >> 12014786

Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories.

John L Schaeffer1, Randal G Ross.   

Abstract

OBJECTIVE: There is increasing interest in the possible relationship between the early diagnosis and treatment of schizophrenia during adolescence and improved long-term outcome. This study reviews the premorbid and prodromal diagnostic and treatment histories for childhood-onset schizophrenia, to assess whether early identification and treatment is possible in this school-age group.
METHOD: Parents of 17 children with childhood-onset schizophrenia or schizoaffective disorder were questioned retrospectively regarding symptoms, exposure to mental health professionals, diagnoses, and treatments.
RESULTS: Initial presenting symptoms clustered around violent aggression and school problems. Age of first recognized psychotic symptoms ranged from 2 to 11 years, followed 2.0+/-2.0 years later by a diagnosis of schizophrenia. Prior to a schizophrenia diagnosis, these children were exposed to stimulants, antidepressants, lower-dose typical neuroleptics, mood stabilizers, alternative treatments, and individual and family therapy.
CONCLUSION: Early diagnosis of childhood-onset schizophrenia is met with caution in the psychological and medical community. These children received many diagnoses before schizophrenia or schizoaffective disorder was diagnosed. A diagnosis of schizophrenia or schizoaffective disorder and utilization of effective atypical neuroleptic treatment was delayed until evaluation by a child and adolescent psychiatrist. Obstacles to early identification and treatment are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12014786     DOI: 10.1097/00004583-200205000-00011

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  19 in total

Review 1.  Developing services for the early detection of psychosis: a critical consideration of the current state of the art.

Authors:  Andor E Simon; Binia Roth; Solange Zmilacher; Emanuel Isler; Daniel Umbricht
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-09-08       Impact factor: 4.785

Review 2.  Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Authors:  Stefano Pallanti; Luana Salerno
Journal:  World J Psychiatry       Date:  2015-03-22

3.  Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management.

Authors:  Jonathan R Stevens; Jefferson B Prince; Laura M Prager; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-13

4.  Stability and prediction of schizophrenia from adolescence to adulthood.

Authors:  Margareth I Helgeland; Svenn Torgersen
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-03       Impact factor: 4.785

Review 5.  Children with schizophrenia: clinical picture and pharmacological treatment.

Authors:  Gabriele Masi; Maria Mucci; Cinzia Pari
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Disentangling the influence of neighborhood and individual characteristics on early residential mobility among newly diagnosed patients with schizophrenia: a multilevel analysis.

Authors:  André Ngamini Ngui; Philippe Apparicio; Marie-Josée Fleury; Jean-Pierre Grégoire; Jocelyne Moisan; Alain Lesage; Alain Vanasse
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

7.  Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period.

Authors:  Vijay A Mittal; Elaine F Walker; Carrie E Bearden; Deborah Walder; Hanan Trottman; Melita Daley; Anthony Simone; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2010-03-15       Impact factor: 13.382

8.  Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors:  Ann E Maloney; Linmarie Sikich
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-10       Impact factor: 2.570

Review 9.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

10.  Use of the ADOS and ADI-R in children with psychosis: importance of clinical judgment.

Authors:  Judith A Reaven; Susan L Hepburn; Randal G Ross
Journal:  Clin Child Psychol Psychiatry       Date:  2008-01       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.